Transcription of SELF-ADMINISTERED DRUG(S) (SAD) - UHCprovider.com Home
{{id}} {{{paragraph}}}
UnitedHealthcare Medicare Advantage Policy Guideline SELF-ADMINISTERED DRUG(S) (SAD). Guideline Number: Approval Date: April 8, 2020. Terms and Conditions Table of Contents Page Related Policies POLICY SUMMARY .. 1 See References APPLICABLE CODES .. 3. DEFINITIONS .. 10. QUESTIONS AND ANSWERS .. 10. PURPOSE .. 10. REFERENCES .. 11. GUIDELINE HISTORY/REVISION INFORMATION .. 13. TERMS AND CONDITIONS .. 14. POLICY SUMMARY. See Purpose Overview The Centers for Medicare and Medicaid Services (CMS) publishes guidelines instructing UnitedHealthcare to develop a process to determine whether a drug or biological is usually SELF-ADMINISTERED and excluded from payment. The program covers drugs that are furnished incident to a physician's service provided that the drugs are not usually administered by the patients who take them.
Self-Administered Drug(s) (SAD) Page 2 of 16 UnitedHealthcare Medicare Advantage Policy Guideline Approved 10/10/2018 Proprietary Information of UnitedHealthcare.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}